Nycomed, as a pioneering pharmaceutical organisation in Australia and New Zealand, is committed to an investment in the countries’ healthcare systems.

With our innovative products and support activities in Sales, Marketing and Research we add value to patients' lives.

We strive for a leadership position in the fields of our expertise, by engaging in constant value innovation and delivering the highest standard in customer service.   
Our performance and long term success provides the foundation for our overall contribution to the Australian and New Zealand societies.  

Two-thirds - or 20,000 - of the diseases and conditions known to medical science cannot be cured or treated adequately at the moment. This is why there will continue to be a great demand for new drugs which are both effective and safe.

As a research-based company with global operations, Nycomed is contributing to sustainable improvements in the quality of patients’ lives by supplying innovative and established therapies. The company researches, develops and produces a wide range of pharmaceuticals.

The main emphasis of its business is prescription drugs from its own research pipeline destined to treat gastrointestinal and respiratory diseases.